Last reviewed · How we verify
Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin Cancers
to compare the effectiveness and safety of intralesional vs. systemic MTX in NMSC management
Details
| Lead sponsor | Zagazig University |
|---|---|
| Phase | PHASE2 |
| Status | COMPLETED |
| Enrolment | 60 |
| Start date | Mon Jul 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Non-melanoma Skin Cancers
Interventions
- Methotrexate
Countries
Egypt